Suchergebnisse - "Wohlfeiler, Michael B"

PubPharm (24)

1

Incident HIV-Associated Wasting/Low Weight Is Associated with Nearly Doubled Mortality Risk in the Modern ART Era

enthalten in: AIDS research and human retroviruses | 2024

von Wohlfeiler, M. | Weber, R. | Brunet, L. | +7

2

Switching to Dolutegravir/Lamivudine Two-Drug Regimen : Durability and Virologic Outcomes by Age, Sex, and Race in Routine US Clinical Care

enthalten in: HIV/AIDS (Auckland, N.Z.) | 2024

von Pierone, G. | Brunet, L. | Fusco, J. | +6

3

Improving Adherence to the Target Window for Cabotegravir + Rilpivirine Long-Acting Injections Through the CHORUS™ App and Web Portal : A Cluster Randomized Trial

enthalten in: Journal of the International Association of Providers of AIDS Care | 2024

von Wohlfeiler, M. | Brunet, L. | Cochran, Q. | +3

4

Definition, Burden, and Predictors of HIV-Associated Wasting and Low Weight in the OPERA Cohort

enthalten in: AIDS research and human retroviruses | 2023

von Wohlfeiler, M. | Weber, R. | Brunet, L. | +7

5

Cabotegravir + Rilpivirine Long-Acting Injections for HIV Treatment in the US : Real World Data from the OPERA Cohort

enthalten in: Infectious diseases and therapy | 2023

von Sension, M. | Brunet, L. | Hsu, R. | +9

6

Cabotegravir + Rilpivirine Long-Acting Injections for HIV Treatment in the US: Real World Data from the OPERA Cohort

enthalten in: Infectious diseases and therapy | 2023

von Sension, M. | Brunet, L. | Hsu, R. | +9

7

HIV retention in care : results and lessons learned from the Positive Pathways Implementation Trial

enthalten in: BMC primary care | 2022

von Wohlfeiler, M. | Weber, R. | Brunet, L. | +7

8

HIV retention in care: results and lessons learned from the Positive Pathways Implementation Trial

enthalten in: BMC primary care | 2022

von Wohlfeiler, M. | Weber, R. | Brunet, L. | +7

9

Perspectives of people living with HIV-1 on implementation of long-acting cabotegravir plus rilpivirine in US healthcare settings : results from the CUSTOMIZE hybrid III implementation-effectiveness study

enthalten in: Journal of the International AIDS Society | 2022

von Garris, C. | Czarnogorski, M. | Dalessandro, M. | +13

10

Perspectives of healthcare providers on implementation of long-acting cabotegravir plus rilpivirine in US healthcare settings from a Hybrid III Implementation-effectiveness study (CUSTOMIZE)

enthalten in: Journal of the International AIDS Society | 2022

von Czarnogorski, M. | Garris, C. | Dalessandro, M. | +13